Skip to main content
Clinical Trials/NCT00371787
NCT00371787CompletedPhase 3

Evaluation of the Performance of Non-molded Soft Contact Lenses

University of Waterloo1 site in 1 country38 target enrollmentStarted: August 1, 2006Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
38
Locations
1
Primary Endpoint
Visual Acuity

Study Overview

Brief Summary

To evaluate the performance of the study soft lens for vision, comfort, physiology and lens surface properties.

Detailed Description

To evaluate the performance of the study soft lens for vision, comfort, physiology and lens surface properties in a group of participants who present with lens related changes.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
17 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Male or female, good health, age >17yrs, able to wear contact lenses as primary vision correction, able to see well and achieve good fit with study lens, has understood & signed consent form.

Exclusion Criteria

  • •Has active ocular disease, uses topical eye medication, wears gas permeable/silicone hydrogel /overnight wear contact lenses, is a participant in another clinical study, is deemed unsuitable for soft contact lens wear.

Arms & Interventions

soft contact lens

Experimental

Intervention: Soft contact lens (Device)

non-lens wear

No Intervention

control group

Outcomes

Primary Outcomes

Visual Acuity

Time Frame: 9 month

level of vision measured using high contrast acuity chart, higher (more positive)logMAR indicates worse vision.

Neovascularisation

Time Frame: baseline

length of the blood vessels entering the superior cornea, higher number means longer blood vessel penetration.

Neovascularization

Time Frame: 9 month

length of the blood vessels entering the superior cornea, higher number means longer blood vessel penetration.

Visual Acuity

Time Frame: baseline

level of vision measured using high contrast acuity chart, higher (more positive)logMAR indicates worse vision.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials